Gemphire Therapeutics

Business Area(s): 


Description: 

Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical-stage biopharmaceutical company that is developing and commercializing therapies to help patients with cardiometabolic disorders, including dyslipidemia and NASH. 

Location(s): 
Livonia MI
United States